Ionis 12-Month FCS Data Position Olezarsen For Near-Term Filing
Executive Summary
Showing its antisense drug can reduce triglycerides and risk of acute pancreatitis in familial chylomicronemia syndrome, Ionis plans to file olezarsen for approval soon, hoping for accelerated approval.